Journal for ImmunoTherapy of Cancer

期刊信息导读

1. Journal for ImmunoTherapy of Cancer基本信息
• 2018-2019最新影响因子
• 年文章数
2. Journal for ImmunoTherapy of Cancer中科院SCI期刊分区
3. 历年Journal for ImmunoTherapy of Cancer影响因子趋势图
4. Journal for ImmunoTherapy of Cancer期刊英文简介
5. Journal for ImmunoTherapy of Cancer期刊中文简介

Journal for ImmunoTherapy of Cancer基本信息

简称：J ImmunoTher Cancer

中文名称：癌症免疫疗法杂志

2018-2019最新影响因子：8.676

SCI类别：无

年文章数：90

PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2051-1426%5BISSN%5D

Journal for ImmunoTherapy of Cancer期刊英文简介

Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed journal that publishes on all aspects of tumor immunology and cancer immunotherapy, aiming to enrich communication and advance scientific understanding in this rapidly evolving field. Topics of interest range across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.

Journal for ImmunoTherapy of Cancer期刊中文简介

《癌症免疫治疗杂志》（JITC）是一本开放的、同行评议的杂志，出版了肿瘤免疫和癌症免疫治疗的各个方面，旨在丰富交流，促进这一快速发展领域的科学理解。感兴趣的主题涵盖基础科学转化临床谱，包括肿瘤宿主相互作用、肿瘤微环境、动物模型、预测和预后免疫生物标志物、新型药物和细胞疗法、疫苗、基于免疫的组合疗法以及免疫相关毒性。

中科院SCI期刊分区：

Journal for ImmunoTherapy of Cancer影响因子

获取相关优质资源获取2023中科院分区